Benefits and safety of omalizumab in the real-world treatment of CIU meet or exceed results gleaned from clinical trials. These real-world data on omalizumab in CIU may help inform both clinical treatment expectations and policy decision making.
No takes yet. Share an insight, caveat, or question.
Tharp et al. (2018) studied this question.